← Leaderboards
Stephen H Thorne
University Of Pittsburgh At Pittsburgh
$3,784,781
Attributed
$3,784,781
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $994.3K · FY2010–20$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$3,784,781 · 4
By mechanism
R01$2,145,229 · 2
R44$1,290,551 · 1
S10$349,001 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Joseph C. Glorioso$19,383,290
- Shigeru Amemiya$3,578,312
- Aaron Paul Batista$7,058,973
- Nirmala Sundarraj$4,169,469
- Paola Grandi$940,989
Others in their field
Top investigators on “Pre-Clinical”
- Leonard Freedman · Leidos Biomedical Research, Inc.$264,541,531
- Dennis R. Burton · Scripps Research Institute$257,157,696
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barton F Haynes · Duke University$186,001,832
- David Heimbrook · Leidos Biomedical Research, Inc.$151,740,590
- Reisa A. Sperling · Banner Health$137,047,788
Research focus
Pre-ClinicalBaseResearch Clinical TestingCellsImmune ResponseImmuneViralProductionTumorVectorOncolytic VirusesVaccinia VirusOncolyticSafetyCancer CellMalignant NeoplasmsVirusAreaOncolytic VectorMutationDesignMediatingNeutralizing AntibodyImmune Targeting
Grant awards (10)
A novel immuno-oncolytic viral therapy for the treatment of non-small cell lung carcinoma$994,294
R44 · FY2020 · CA · contact PI
A novel immuno-oncolytic viral therapy for the treatment of non-small cell lung carcinoma$296,257
R44 · FY2019 · CA · contact PI
Creation of Immuno-Oncolytic Viruses for Cancer Therapy$319,550
R01 · FY2015 · CA · contact PI
Creation of Immuno-Oncolytic Viruses for Cancer Therapy$319,031
R01 · FY2014 · CA · contact PI
Enhancing Delivery and Regulating Gene Expression in Oncolytic Vaccinia Vectors$295,784
R01 · FY2014 · CA · contact PI
Enhancing Delivery and Regulating Gene Expression in Oncolytic Vaccinia Vectors$286,637
R01 · FY2013 · CA · contact PI
Enhancing Delivery and Regulating Gene Expression in Oncolytic Vaccinia Vectors$304,932
R01 · FY2012 · CA · contact PI
Request for Whole Animal Tomographic Fluorescence Imaging Equipment$349,001
S10 · FY2011 · RR · contact PI
Enhancing Delivery and Regulating Gene Expression in Oncolytic Vaccinia Vectors$304,932
R01 · FY2011 · CA · contact PI
Enhancing Delivery and Regulating Gene Expression in Oncolytic Vaccinia Vectors$314,363
R01 · FY2010 · CA · contact PI